Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck

The hazard of accelerated tumor clonogen repopulation during radiotherapy

H. Rodney Withers, Jeremy M. G. Taylor, B. Maciejewski · Acta Oncologica · 1988 · 1.6K citations · Full text

Medicine, Oncology, Radiation Oncology +14

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu, Thomas F. Pajak, Andy Trotti et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.4K citations

Medicine, Oncology, Radiation Oncology +17

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

Jean-Claude Horiot, P. Bontemps, Walter Van den Bogaert et al. · Radiotherapy and Oncology · 1997 · 505 citations

Medicine, Oncology, Radiation Oncology +17

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

Stanley Dische, Michele I. Saunders, Ann Barrett et al. · Radiotherapy and Oncology · 1997 · 472 citations

Medicine, Oncology, Radiation Oncology +7

p53 Mutation and Locoregional Treatment Failure in Head and Neck Squamous Cell Carcinoma

Wayne M. Koch, Jaclyn A. Brennan, Marianna Zahurak et al. · JNCI Journal of the National Cancer Institute · 1996 · 233 citations · Full text

Medicine, Oncology, Radiation Oncology +14